BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10227098)

  • 21. [Rheumatoid arthritis. Conservative therapeutic possibilities today and in the future].
    Aeschlimann AG
    Orthopade; 1998 Mar; 27(3):160-5. PubMed ID: 9585923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of early rheumatoid arthritis.
    Geletka R; St Clair EW
    Best Pract Res Clin Rheumatol; 2003 Oct; 17(5):791-809. PubMed ID: 12915158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981-1996.
    Ward MM; Fries JF
    J Rheumatol; 1998 Mar; 25(3):408-16. PubMed ID: 9517756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
    Ciubotariu E; Gabay C; Finckh A;
    J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, Synthesis and In Vitro Release Studies of Co-Drugs for Rheumatoid Arthritis.
    Kashmira P; Dhaneshwar S; Shakuntala C; Poorvashree J
    Inflamm Allergy Drug Targets; 2015; 14(1):47-52. PubMed ID: 26631094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rheumatoid arthritis. Diagnosis, anatomopathology, evolution, prognosis, treatment].
    Jean-Baptiste G
    Rev Prat; 1991 Sep; 41(19):1863-8. PubMed ID: 1681584
    [No Abstract]   [Full Text] [Related]  

  • 28. Practice variation in the treatment of rheumatoid arthritis among German rheumatologists.
    Zink A; Listing J; Ziemer S; Zeidler H;
    J Rheumatol; 2001 Oct; 28(10):2201-8. PubMed ID: 11669156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial.
    Matteson EL; Weyand CM; Fulbright JW; Christianson TJ; McClelland RL; Goronzy JJ
    Rheumatology (Oxford); 2004 May; 43(5):619-25. PubMed ID: 14983105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic strategies for rheumatoid arthritis.
    O'Dell JR
    N Engl J Med; 2004 Jun; 350(25):2591-602. PubMed ID: 15201416
    [No Abstract]   [Full Text] [Related]  

  • 31. Rheumatoid arthritis: a clinical overview of new diagnostic and treatment approaches.
    Sanmartí R; Ruiz-Esquide V; Hernández MV
    Curr Top Med Chem; 2013; 13(6):698-704. PubMed ID: 23574518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in the pharmacological management of rheumatoid arthritis over two decades.
    Crossfield SSR; Buch MH; Baxter P; Kingsbury SR; Pujades-Rodriguez M; Conaghan PG
    Rheumatology (Oxford); 2021 Sep; 60(9):4141-4151. PubMed ID: 33404652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of combination nonbiologic disease-modifying antirheumatic drug strategies in patients with early rheumatoid arthritis.
    Tosh JC; Wailoo AJ; Scott DL; Deighton CM
    J Rheumatol; 2011 Aug; 38(8):1593-600. PubMed ID: 21572149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway.
    Nikolaisen C; Kvien TK; Mikkelsen K; Kaufmann C; Rødevand E; Nossent JC
    Scand J Rheumatol; 2009; 38(4):240-5. PubMed ID: 19229766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.
    van der Woude D; Young A; Jayakumar K; Mertens BJ; Toes RE; van der Heijde D; Huizinga TW; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2262-71. PubMed ID: 19644846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment Patterns of Multimorbid Patients with Rheumatoid Arthritis: Results from an International Cross-sectional Study.
    Radner H; Yoshida K; Hmamouchi I; Dougados M; Smolen JS; Solomon DH
    J Rheumatol; 2015 Jul; 42(7):1099-104. PubMed ID: 26034147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and management of rheumatoid arthritis.
    Rindfleisch JA; Muller D
    Am Fam Physician; 2005 Sep; 72(6):1037-47. PubMed ID: 16190501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease-modifying anti-rheumatic drug therapy and structural damage in early rheumatoid arthritis.
    Mullan RH; Bresnihan B
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S158-64. PubMed ID: 14969069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug treatment for rheumatoid arthritis.
    Langenegger T; Michel BA
    Clin Orthop Relat Res; 1999 Sep; (366):22-30. PubMed ID: 10627714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Utrecht experience with different treatment strategies in early rheumatoid arthritis.
    Verstappen SM; Jacobs JW; Bijlsma JW;
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S165-8. PubMed ID: 14969070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.